The Ten Mistakes that Senior Management Teams make with INDs March 2, 2010

The Ten Mistakes That Senior Management Teams Make with Investigational New Drug Applications

Agenda
12:00 PM - 12:30 PM Registration, Lunch, and Networking
12:30 PM - 2:00 PM Presentation & Panel Discussion

Senior Management teams face many challenges when working on Investigational New Drug applications (INDs). These are not easy applications to create, and there are many potential pitfalls. During the presentation the requirements for an IND will be explored and the potential pitfalls that CEOs and senior management teams need to be aware of will be identified. A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel.

Speakers
- Panel Chair: Debra Gosling, Account Executive, Liquent Regulatory & Clinical Services, Thomson Reuters
- Lorna Speid, M.R.Pharm.S., Ph.D., RAC., President, Speid & Associates, Inc.
- Tom Delisi, Senior Consultant, Liquent Regulatory Services, Thomson Reuters
- Kathryn Plank, Senior Regulatory Consultant, Liquent Direct, Thomson Reuters
- Jim Hilferty, Operations Manager, Liquent Regulatory & Clinical Services, Thomson Reuters

Venue
The San Jose BioCenter
5941 Optical Court
San Jose, CA 95138

Cost & Registration
*Pre-registration closes on March 1st at noon!*
- Regular Price: $30
- Partners' Network: $20
- BioCenter Members: Free (please RSVP to Aurelie)
- On-site Registration: add $10 to the above
Space is limited for this event, so early so pre-registration is recommended to avoid disappointment on the day!

Official Website: http://www.sjbiocenter.com/event/ev_2010Q1-IND.html